Press Releases April 1, 2026 08:00 PM

Rush Enterprises, Inc. Conference Call Advisory for First Quarter 2026 Earnings Results

Rush Enterprises Announces Date for Q1 2026 Earnings Conference Call

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn

Rush Enterprises, the largest commercial vehicle dealership network in North America, announced it will host a conference call to discuss its first quarter 2026 earnings results on April 29, 2026, following the earnings release on April 28. The call will provide insights into the company's operational and financial performance across its extensive dealership and service network.

Rush Enterprises, Inc. Conference Call Advisory for First Quarter 2026 Earnings Results
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Rush Enterprises operates over 150 commercial vehicle dealerships across 23 U.S. states and Ontario, Canada, representing major truck and bus manufacturers.
  • The company offers a comprehensive set of services including sales of new and used vehicles, aftermarket parts, service, financing, leasing, and telematics products.
  • The upcoming earnings call will update investors on the company’s first quarter performance and outlook for 2026.

NEW BRAUNFELS, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Rush Enterprises, Inc., (NASDAQ: RUSHA & RUSHB), which operates the largest network of commercial vehicle dealerships in North America will host a conference call to discuss earnings for the first quarter 2026 on Wednesday, April 29, 2026 at 10:00 a.m. Eastern/9:00 a.m. Central. Earnings will be reported after the close of market on Tuesday, April 28, 2026.

The call will be available at http://investor.rushenterprises.com/events.cfm on Wednesday, April 29, 2026 at 10:00 a.m. Eastern/9:00 a.m. Central.

Participants may register for the call at:
https://register-conf.media-server.com/register/BI31f424b7e9f24f34915b723b0fb189bd
While not required, it is recommended that you join the event 10 minutes prior to the start.

For those who cannot listen to the live broadcast, the webcast replay will be available at http://investor.rushenterprises.com/events.cfm.

About Rush Enterprises, Inc.
Rush Enterprises, Inc. is the premier solutions provider to the commercial vehicle industry. The Company owns and operates Rush Truck Centers, the largest network of commercial vehicle dealerships in North America, with more than 150 locations in 23 states and Ontario, Canada. These vehicle centers, strategically located in high traffic areas on or near major highways throughout the United States and Ontario, Canada, represent truck and bus manufacturers, including Peterbilt, International, Hino, Isuzu, Ford, IC Bus and Blue Bird. They offer an integrated approach to meeting customer needs – from sales of new and used vehicles to aftermarket parts, service and body shop operations plus financing, insurance, leasing and rental. Rush Enterprises' operations also provide CNG fuel systems (through its investment in Cummins Clean Fuel Technologies, Inc.), telematics products and other vehicle technologies, as well as vehicle up-fitting, chrome accessories and tires. For more information, please visit us at www.rushtruckcenters.com, www.rushenterprises.com and www.rushtruckcentersracing.com, on Twitter @rushtruckcenter and Facebook.com/rushtruckcenters.

Contact:
Rush Enterprises, Inc., New Braunfels, Texas
Steve Keller (830) 302-5226


Risks

  • Performance depends on the commercial vehicle industry's economic cycles, which can impact sales and service demand, particularly in transportation and logistics sectors.
  • Exposure to multiple manufacturers means potential supply chain disruptions or manufacturer issues could affect inventory and sales.
  • Market uncertainties such as fluctuating fuel prices and regulatory changes in transportation can impact operating costs and demand for fleet services.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026